{"id":31876,"date":"2018-09-20T13:24:00","date_gmt":"2018-09-20T11:24:00","guid":{"rendered":"https:\/\/gsk-lux.com\/interview-with-arne-bolch-luxembourg-funds-innovative-and-reliable\/"},"modified":"2018-09-20T13:24:00","modified_gmt":"2018-09-20T11:24:00","slug":"interview-with-arne-bolch-luxembourg-funds-innovative-and-reliable","status":"publish","type":"post","link":"https:\/\/gsk-lux.com\/en\/interview-with-arne-bolch-luxembourg-funds-innovative-and-reliable\/","title":{"rendered":"Interview with Arne Bolch: &#8220;Luxembourg funds\u2009\u2013\u2009innovative and reliable\u201d"},"content":{"rendered":"<\/p>\n<p>With roughly \u20ac4.2 trillion assets under management, approximately 300 management companies\/AIFMs selling 70% of European OGAW funds within the EU and in places as far away as Chile and Japan, the Grand Duchy provides today a proven safe environment for investing in funds. Luxembourg funds are \u201ctried and tested\u201d; buying a Sicav is something many institutional investors have grown familiar with. How did this develop, how does Luxembourg maintain its leading position?<\/p>\n<p><a href=\"https:\/\/paperjam.lu\/article\/news-luxembourg-funds-innovative-and-reliable\">https:\/\/paperjam.lu\/article\/news-luxembourg-funds-innovative-and-reliable<\/a><\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>With roughly \u20ac4.2 trillion assets under management, approximately 300 management companies\/AIFMs selling 70% of European OGAW funds within the EU and in places as far away as Chile and Japan, the Grand Duchy provides today a proven safe environment for investing in funds. Luxembourg funds are \u201ctried and tested\u201d; buying a Sicav is something many &hellip; <a href=\"https:\/\/gsk-lux.com\/en\/interview-with-arne-bolch-luxembourg-funds-innovative-and-reliable\/\">Continued<\/a><\/p>\n","protected":false},"author":35,"featured_media":31052,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[630],"tags":[],"ausgabe":[],"class_list":["post-31876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media-review"],"acf":{"postdownloads_lux":null,"pressekontakt":{"name":"","email":"","phone":""},"ansprechpartner":null},"_links":{"self":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/comments?post=31876"}],"version-history":[{"count":0,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/posts\/31876\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media\/31052"}],"wp:attachment":[{"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/media?parent=31876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/categories?post=31876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/tags?post=31876"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk-lux.com\/en\/wp-json\/wp\/v2\/ausgabe?post=31876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}